Christina P.: Exploring Joint Involvement and Musculoskeletal Symptoms in Antiphospholipid Syndrome
Christina P., CEO and Co-Founder of APS Foundation of America, shared a post on LinkedIn about a recent article by Maria Ribeiro et al. published in Sage Journals, adding:
“Articular involvement in antiphospholipid syndrome: Clinical, laboratory, and imaging characterization
A new study investigated joint pain, stiffness, and inflammation in people with primary antiphospholipid syndrome (APS) and those with APS associated with systemic lupus erythematosus (SLE).
Researchers examined 99 participants, including 38 with primary APS, 26 with APS and lupus, and 35 healthy controls. Participants underwent clinical assessments, laboratory testing, X-rays, and high-resolution ultrasound examinations of their hands and wrists.
Key Findings
- Joint pain was common: 50% of patients with primary APS and 80.8% of those with APS and lupus reported joint pain.
- Morning stiffness was more frequent with lupus: 46.2% of APS/lupus patients experienced morning stiffness compared with 21.1% of primary APS patients.
Inflammation was not always detectable: Despite frequent joint symptoms, imaging and laboratory tests often showed little evidence of active inflammation. - Joint fluid was more common in APS/lupus: Ultrasound detected joint effusions in 26.9% of APS/lupus patients compared with just 2.6% of primary APS patients.
- Traditional inflammatory markers were inconsistent: ESR was higher in APS/lupus patients, but CRP levels did not differ significantly between groups.
What Does This Mean for APS Patients?
The findings suggest that joint pain in APS may occur without obvious signs of inflammation, indicating that mechanisms other than traditional inflammatory arthritis could contribute to musculoskeletal symptoms.
Importantly, the absence of significant inflammatory findings on imaging or blood tests does not mean a patient’s pain is nonexistent.
Researchers concluded that joint involvement is common in APS, particularly when lupus is also present, and further research is needed to understand the underlying mechanisms.
Because this was a relatively small, cross-sectional study, it cannot establish the cause of joint symptoms or whether these findings apply to all APS patients.
Key Takeaway for the APS Community
Joint pain is a recognized concern in APS, even when conventional inflammatory testing appears normal. This research reinforces the importance of recognizing musculoskeletal symptoms in APS patients and investigating their causes rather than relying exclusively on inflammatory markers.”
Title: Articular involvement in antiphospholipid syndrome: Clinical, laboratory, and imaging characterization
Authors: Maria Ribeiro, Flavio Signorelli, Gustavo Balbi, Karina Bonfiglioli, João Rodrigues, Lissiane Guedes, Danieli Andrade

Find more posts featuring Christina P. on Hemostasis Today.
-
Nov 21, 2026, 15:30Amin Marashi: How Does the Microbiome Trigger the Immune System to Suddenly Turn Against the Body’s Own Blood-Clotting Regulators?
-
Nov 21, 2026, 14:4410 Posts Not to Miss This Week
-
Nov 21, 2026, 14:21Two Emerging Mechanisms Linking Sickle Cell Disease to Thrombosis
-
Nov 21, 2026, 13:06Christine Faressa: Precision PRP and Platelet Biology in Musculoskeletal Care
-
Nov 21, 2026, 13:04Eyad Jamileh: Atrial Fibrillation – Bridging the Global Gaps in Diagnosis and Stroke Prevention
-
Nov 21, 2026, 12:49Thibault Veyron: Optimizing Bivalirudin Treatment in HIT
-
Nov 21, 2026, 12:44Paulus Kirchhof: Left Atrial Appendage Occlusion vs DOACs
-
Nov 21, 2026, 12:19Jiyeon Kim: Human Platelet Lysate – Advancing Cell Therapy and Space Research
-
Nov 21, 2026, 12:13Chaza Alaji: DVT in Early Pregnancy – Why Anticoagulation Decisions Matter